Reactive arthritis (ReA) following the first dose of Covid-19 vaccine: A case report


Covid-19; Vaccination; reactive arthritis; Pfizer-BioNTech vaccine

How to Cite

Draz, H., & Khalifa, A. (2022). Reactive arthritis (ReA) following the first dose of Covid-19 vaccine: A case report. Rheumatology (Bulgaria), 30(1), 95-98.


Introduction: The development of vaccination against COVID-19 infection was a promising step during the battle against this pandemic; however, some vaccines were associated with some complications starting with just flu-like symptoms up to anaphylaxis; of the reported complications is joints pain. Here, we report a case who developed reactive arthritis (ReA) after receiving the first dose of the Pfizer-BioNTech Covid-19 vaccine.

Case presentation: A healthy 54 years old male with no previous history of any medical condition was presented with bilateral hand and bilateral knee pain after one week of receiving his first dose of Pfizer-BioNTech Covid-19 vaccine. Clinical examination revealed swelling, tenderness, and erythema over the right index metacarpophalangeal joint and the medial aspect of the right knee. Radiographs of the hand and knee were normal. Laboratory investigations were within normal values except for an elevated ESR (15 mm/hr.) and a positive CRP titer of 48 mg/l. The symptoms entirely resolved after two weeks of non-steroidal anti-inflammatory medications.

Conclusions: Although rare, however, ReA could be presented as a complication of Covid-19 vaccination, and physicians should be aware of the possibility of its occurrence.


  1. Banerji A, Wickner PG, Saff R, Stone CA, Jr., Robinson LB, Long AA, Wolfson AR, Williams P, Khan DA, Phillips E, Blumenthal KG (2021) mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach. J Allergy Clin Immunol Pract 9 (4):1423-1437. doi:10.1016/j.jaip.2020.12.047
  2. Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC (2021) COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. European review for medical and pharmacological sciences 25 (3):1663-1669. doi:10.26355/eurrev_202102_24877
  3. Pennisi M, Perdue J, Roulston T, Nicholas J, Schmidt E, Rolfs J (2019) An overview of reactive arthritis. JAAPA 32 (7):25-28. doi:10.1097/01.JAA.0000558320.47868.2f
  4. Garcia-Kutzbach A, Chacon-Suchite J, Garcia-Ferrer H, Iraheta I (2018) Reactive arthritis: update 2018. Clinical rheumatology 37 (4):869-874. doi:10.1007/s10067-018-4022-5
  5. Mahran MA, Khalifa AA, Elsherif ME, Refai O (2021) Neglected reactive arthritis complicated by bilateral hip and temporomandibular joints ankylosis after a suspected tetanus infection: a case report. The Egyptian Journal of Internal Medicine 33 (1):1-5
  6. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z (2020) Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). Journal of general internal medicine 35 (5):1545-1549. doi:10.1007/s11606-020-05762-w
  7. Shokraee K, Moradi S, Eftekhari T, Shajari R, Masoumi M (2021) Reactive arthritis in the right hip following COVID-19 infection: a case report. Tropical diseases, travel medicine and vaccines 7 (1):18. doi:10.1186/s40794-021-00142-6
  8. Gasparotto M, Framba V, Piovella C, Doria A, Iaccarino L (2021) Post-COVID-19 arthritis: a case report and literature review. Clinical rheumatology:1-6. doi:10.1007/s10067-020-05550-1
  9. Sureja NP, Nandamuri D (2021) Reactive arthritis after SARS-CoV-2 infection. Rheumatology advances in practice 5 (1):rkab001. doi:10.1093/rap/rkab001
  10. Sahin N, Salli A, Enginar AU, Ugurlu H (2009) Reactive arthritis following tetanus vaccination: a case report. Modern rheumatology 19 (2):209-211. doi:10.1007/s10165-008-0140-2
  11. Kaul A, Adler M, Alokaily F, Jawad AS (2002) Recurrence of reactive arthritis after a booster dose of tetanus toxoid. Annals of the rheumatic diseases 61 (2):185. doi:10.1136/ard.61.2.185
  12. Kesiktaş FN, Yemisen M, Gün K, Uludağ M, Dernek B (2015) A Case of Reactive Arthritis Developed After Tetanus Vaccine. İstanbul Kanuni Sultan Süleyman Tıp dergisi 7 (3):147-149. doi:10.5222/iksst.2015.147
  13. An QJ, Qin DA, Pei JX (2021) Reactive arthritis after COVID-19 vaccination. Human vaccines & immunotherapeutics:1-3. doi:10.1080/21645515.2021.1920274
  14. Agarwal MP, Giri S, Sharma V, Bhardwaj G (2009) Concurrent reactive arthritis and myelitis - a case report. International archives of medicine 2 (1):17. doi:10.1186/1755-7682-2-17
  15. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW, Jr., Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Jansen KU, Gruber WC (2020) Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. The New England journal of medicine 383 (27):2603-2615. doi:10.1056/NEJMoa2034577
  16. Velikova T, Georgiev T (2021) SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatology international 41 (3):509-518. doi:10.1007/s00296-021-04792-9
  17. THE FACTS ABOUT THE PFIZER-BIONTECH COVID-19 VACCINE, How does an mRNA vaccine work? Accessed 20-6 2021
  18. Sell S (2019) How vaccines work: immune effector mechanisms and designer vaccines. Expert review of vaccines 18 (10):993-1015. doi:10.1080/14760584.2019.1674144
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.